Intrathecal meperidine attenuates shivering induced by spinal anesthesia

J. C. Chen, S. W. Hsu, L. H. Hu, Y. J. Hong, P. S. Tsai, T. C. Lin, C. F. Lin, T. T. Wei

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)


Shivering is a common and complex phenomenon that occurs in many patients during spinal anesthesia. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. The metabolic costs and cardiorespiratory consequences of shivering are important particularly for patients with anemia, coronary arterial disease, cardiopulmonary insufficient, debilitated status or are elderly. We studied whether intrathecal meperidine could prevent shivering after spinal anesthesia. 60 patients with ASA class I-II were divided into intrathecal meperidine group (Group I) (n = 30) and control group (Group II) (n = 30). Group I received spinal tetracaine 12-16 mg with meperidine 0.2 mg/kg and Group II received spinal tetracaine 12-16 mg without meperidine. During operation the highest level of spinal anesthesia, ambient and rectal temperatures, blood pressure (BP) and heart rate (HR), presence or absence of shivering, intensity of shivering in both groups were recorded. Close observation for side effects was given post-operatively. There was a significant reduction (p < .005) in incidence of shivering in group I patients (16.7%) when compared with group II (56.7%). There was no or less side effects observed with other neuraxial opioids except nausea. We concluded that intrathecal meperidine could suppress shivering induced by spinal anesthesia.

頁(從 - 到)19-24
期刊Ma zui xue za zhi = Anaesthesiologica Sinica
出版狀態已發佈 - 三月 1 1993

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

指紋 深入研究「Intrathecal meperidine attenuates shivering induced by spinal anesthesia」主題。共同形成了獨特的指紋。